The Patent Finder

Laboratorios Salvat, S.A.

Also on record
Records under this name other than the patents Laboratorios Salvat, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Laboratorios Salvat, S.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,040,701Apaf-1 inhibitor compounds
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,524,894Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
Lapsed on the fee record
Ended Sep 3, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 3, 2025USPTO record
US 8,822,452Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
Lapsed on the fee record
Ended Sep 2, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 2, 2022USPTO record
US 8,871,787Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester
Lapsed on the fee record
Ended Oct 28, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 28, 2018USPTO record
US 7,115,629Carbamates derived from arylalkylamines
Lapsed on the fee record
Ended Oct 3, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 3, 2018USPTO record
US 8,492,402Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester
Lapsed on the fee record
Ended Jul 23, 2017 · USPTO record
Lapsed on the fee recordEnded Jul 23, 2017USPTO record
US 6,916,828Carbamates derivatived from arylakylamines
Lapsed on the fee record
Ended Jul 12, 2017 · USPTO record
Lapsed on the fee recordEnded Jul 12, 2017USPTO record
US 7,452,9041-Alkyl-1-Azoniabicyclo' 2.2.2 Octane Carbamate Derivatives and Their Use as Muscarinic Receptor Antagonists
Formerly held
Lapsed on the fee record
Ended Nov 18, 2016 · High confidence
Lapsed on the fee recordEnded Nov 18, 2016High confidence
US 7,423,172Tyrosine derivatives as PPAR-γ-modulators
Lapsed on the fee record
Ended Sep 9, 2012 · USPTO record
Lapsed on the fee recordEnded Sep 9, 2012USPTO record
US 6,670,365Substituted imidazo 1,2a}azines as selective inhibitors of cox-2
Lapsed on the fee record
Ended Dec 30, 2007 · USPTO record
Lapsed on the fee recordEnded Dec 30, 2007USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited